Company intelligence / Profile preview
Greenlife Pharmaceuticals
Lagos, Lagos, Nigeriagreenlifepharmaceuticals.com ↗
- Ownership
- Private
- Employees
- ~500
- Development stage
- Other
01
Overview
Greenlife Pharmaceuticals has a broad portfolio of commercialized generic and branded medicines in Nigeria and West Africa. Its flagship product Lonart-Ds was among the first in Nigeria to use NAFDAC’s anti-counterfeiting technology. The company focuses on affordable access to essential medicines for malaria and other common diseases[5][1].
- Therapeutic areas
- Metabolic DisordersInfectious DiseasesDermatologyRheumatologyCardiovascular
- Modalities
- Small moleculeNon-pharmacological therapy
- Industry
- Biotech
02
Drug pipeline
6 assets5 more assets in the full pipeline.
Request access →03
Partnerships
NAFDAC
Beyond the preview
Go deeper on Greenlife Pharmaceuticals.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Greenlife Pharmaceuticals.